secwatch.observer — SEC 8-K summary
======================================

Issuer:     SWK Holdings Corp (SWKHL)
CIK:        0001089907
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001552781-24-000405
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SWK Holdings names new CFO, repurchases $1M in stock, provides portfolio updates
--------------------------------------------------------------------------------

- Adam Rice, CPA, joined as CFO in July; Courtney Baker promoted to Controller.
- Repurchased 58,567 shares for $1.0M in Q2; YTD through July 15 bought 197,969 shares for $3.4M.
- Funded $2.0M term loan to AOTI in May; Journey Medical drew $5.0M additional term loan in June.
- Journey Medical can draw incremental $5.0M upon FDA approval of DFD-29 (PDUFA Nov 4, 2024).
- Portfolio companies AOTI, Biolase, Biotricity, Elutia, Eton, Journey, Shield reported progress.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1089907/000155278124000405/0001552781-24-000405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1089907/000155278124000405/e24312_swkh-8k.htm
  HTML page:      https://secwatch.observer/filing/0001552781-24-000405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer